More on ALLO

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (7.0 Score)

Upcoming Events

- Earnings (8/5/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Allogene Therapeutics (NQ:ALLO)
Delayed: 1.79 --0 (-0%)
Prev. Close $1.79  
Open$1.75 
52 Wk High$ 
52 Wk Low$ 
Day High$1.83 
Day Low$1.74 
P/E N/A  
EPS$ 
Volume4,939,745 

Friends, Peers and Foes (?): ALCLS, CLLS, CHRS, ELVN, ONCY (more...)

Jul 15, 2026 08:30 AM Allogene's CAR T therapy shows 31% response rate in kidney cancer
Jul 15, 2026 08:30 AM Allogene Therapeutics Announces Journal of Clinical Oncology Publication of Phase 1 Results of ALLO-316 Highlighting First Durable Remissions Following Allogeneic CAR T for Treatment of Metastatic Sol
Jul 6, 2026 05:51 PM Form 4 Allogene Therapeutics, For: Jul 01 Filed by: Roberts Zachary
Jun 23, 2026 04:35 PM Form 4 Allogene Therapeutics, For: Jun 18 Filed by: Kazam Joshua A
Jun 23, 2026 04:34 PM Form 4 Allogene Therapeutics, For: Jun 18 Filed by: MESSEMER DEBORAH M.
Jun 23, 2026 04:33 PM Form 4 Allogene Therapeutics, For: Jun 18 Filed by: Mayo Stephen
Jun 23, 2026 04:32 PM Form 4 Allogene Therapeutics, For: Jun 18 Filed by: SATO VICKI L
Jun 23, 2026 04:30 PM Form 4 Allogene Therapeutics, For: Jun 18 Filed by: WITTE OWEN N.
Jun 23, 2026 04:28 PM Form 4 Allogene Therapeutics, For: Jun 18 Filed by: Humer Franz B
Jun 23, 2026 04:27 PM Form 4 Allogene Therapeutics, For: Jun 18 Filed by: Barrett Elizabeth A.
View All Articles

Entities mentioned with ALLO

View All Entities